Methanol PoisoningNCT04064801
Red Cell Distribution Width as a Predictor of Mortality in Acute Methanol Poisoning
An observational study of Methanol Poisoning, run by Adana Numune Training and Research Hospital at 1 site in Turkey (Türkiye).
Trial summary
The study aimed to investigate the association between RDW and in-hospital mortality in methanol poisoning. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Methanol Poisoning
- How many people
- 42 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 Mar 2020to 30 Aug 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients with acute methanol toxicity who were diagnosed and treated at the Adana City Training and Research Hospital
Who may be able to join
- All patients aged ≥18 years who were admitted to emergency departments from January 2019 to January 2020 on account of acute methanol intoxication.
Who cannot join
- Incomplete data, Malignancy, Severe anaemia, History of erythrocyte transfusion last 6 weeks
- -
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Adana City Training and Research Hospital
Adana, 01170
About this study
The study aimed to investigate the association between RDW and in-hospital mortality in methanol poisoning.
Read the detailed description
RDW values have been found to be an independent predictor of the prognosis among patients with heart diseases, stroke,community-acquired pneumonia (CAP), pulmonary embolism, chronic obstructive pulmonary disease (COPD), septic shock, and acute pancreatitis.
- Conditions
- Methanol Poisoning
- Keywords
- Alcohol, red blood cell distribution width, methanol poisoning, prognosis
What is being measured
The primary outcome is the main question the study is designed to answer.
Hospital mortality
Measured: 7 day
Need for mechanical ventilation
Measured: 7 day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Aug 2019
- Study start15 Mar 2020
- Primary completion30 May 2020
- Study completion30 Aug 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Methanol PoisoningStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 42 participants (actual)
Sponsor and investigators
- Lead sponsor
- Adana Numune Training and Research Hospital
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Barış Arslan, Adana Numune Training and Research Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04064801
- Sponsor's protocol ID
- AdanaCTYHOSP
- Status last verified
- Apr 2021
- First submitted
- 20 Aug 2019
- Last updated
- 15 Apr 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Apr 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Red Cell Distribution Width as a Predictor of Mortality in Acute Methanol Poisoning
- ClinicalTrials.gov ID
- NCT04064801
- Acronym / sponsor ID
- AdanaCTYHOSP
- Conditions
- Methanol Poisoning
- Keywords
- Alcohol, red blood cell distribution width, methanol poisoning, prognosis
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 42 participants (actual)
- Lead sponsor
- Adana Numune Training and Research HospitalOther government
- Study start
- 15 Mar 2020 (actual)
- Primary completion
- 30 May 2020 (actual)
- Study completion
- 30 Aug 2020 (actual)
- First posted
- 22 Aug 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study aimed to investigate the association between RDW and in-hospital mortality in methanol poisoning.
Detailed description
RDW values have been found to be an independent predictor of the prognosis among patients with heart diseases, stroke,community-acquired pneumonia (CAP), pulmonary embolism, chronic obstructive pulmonary disease (COPD), septic shock, and acute pancreatitis.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with acute methanol toxicity who were diagnosed and treated at the Adana City Training and Research Hospital
Key inclusion criteria (1 listed)
- All patients aged ≥18 years who were admitted to emergency departments from January 2019 to January 2020 on account of acute methanol intoxication.
Key exclusion criteria (2 listed)
- Incomplete data, Malignancy, Severe anaemia, History of erythrocyte transfusion last 6 weeks
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Hospital mortality
Time frame: 7 day
Need for mechanical ventilation
Time frame: 7 day
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Apr 2021.
- Individual participant dataSharing planned: No
Related trials for Methanol Poisoning
RecruitingObservational study
A Study on Bedside Formate Assay as a Diagnostic Tool in Methanol Poisoning
Metabolic Acidosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Methanol Poisoning, run by Adana Numune Training and Research Hospital at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Hospital mortality (time frame: 7 day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Apr 2021.